"Designing Growth Strategies is in our DNA"

Skin Cancer Treatment Market Size, Share & Industry Analysis, By Disease Indication (Melanoma and Non-Melanoma), By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Radiation Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI102806

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Skin Cancer - by Region
    2. Key Mergers, Acquisition, and Partnerships
    3. Pipeline Analysis
    4. New Product Introductions/ Approvals- by Major Players
    5. Overview of Regulatory Scenario - Key Countries
  5. Global Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis, Insights and Forecast – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Skin Cancer Treatment Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Melanoma
      2. Non-melanoma
    3. Market Analysis – By Therapy
      1. Immunotherapy
      2. Targeted Therapy
      3. Chemotherapy
      4. Radiation Therapy
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Merck & Co.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Bristol Myers Squibb Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Amgen Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. GlaxoSmithKline plc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Regeneron Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Skin Cancer Treatment Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 2:  Global Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019 & 2027

Figure 3:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Melanoma, 2016-2027

Figure 4:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Non-melanoma, 2016-2027

Figure 5:  Global Skin Cancer Treatment Market Value Share (%), by Therapy, 2019 & 2027

Figure 6:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Immunotherapy, 2016-2027

Figure 7:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Targeted Therapy, 2016-2027

Figure 8:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Chemotherapy, 2016-2027

Figure 9:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Radiation Therapy, 2016-2027

Figure 10:  Global Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 11:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Hospital Pharmacy , 2016-2027

Figure 12:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Retail Pharmacy , 2016-2027

Figure 13:  Global Skin Cancer Treatment Market Forecast (US$ Bn), by Others, 2016-2027

Figure 14:  Global Skin Cancer Treatment Market Value (US$ Bn), by Region, 2019 & 2027

Figure 15:  North America Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 16:  North America Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 17:  North America Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 18:  North America Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 19:  North America Skin Cancer Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 20:  North America Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 21:  North America Skin Cancer Treatment Market Value (US$ Bn), By Country, 2019 & 2027

Figure 22:  North America Skin Cancer Treatment Market Value Share (%), By Country, 2019

Figure 23:  Europe Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 24:  Europe Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 25:  Europe Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 26:  Europe Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 27:  Europe Skin Cancer Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 28:  Europe Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 29:  Europe Skin Cancer Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 30:  Europe Skin Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 31:  Asia Pacific Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 32:  Asia Pacific Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 33:  Asia Pacific Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 34:  Asia Pacific Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 35:  Asia Pacific Skin Cancer Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 36:  Asia Pacific Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 37:  Asia Pacific Skin Cancer Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 38:  Asia Pacific Skin Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 39:  Latin America Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 40:  Latin America Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 41:  Latin America Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 42:  Latin America Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 43:  Latin America Skin Cancer Treatment Market Value (US$ Bn), by Modality, 2019 & 2027

Figure 44:  Latin America Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 45:  Latin America Skin Cancer Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 46:  Latin America Skin Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 47:  Middle East & Africa Skin Cancer Treatment Market Value (US$ Bn), by Disease Indication, 2019 & 2027

Figure 48:  Middle East & Africa Skin Cancer Treatment Market Value Share (%), by Disease Indication, 2019

Figure 49:  Middle East & Africa Skin Cancer Treatment Market Value (US$ Bn), by Therapy, 2019 & 2027

Figure 50:  Middle East & Africa Skin Cancer Treatment Market Value Share (%), by Therapy, 2019

Figure 51:  Middle East & Africa Skin Cancer Treatment Market Value (US$ Bn), by Distribution Channel, 2019 & 2027

Figure 52:  Middle East & Africa Skin Cancer Treatment Market Value Share (%), by Distribution Channel, 2019

Figure 53:  Middle East & Africa Skin Cancer Treatment Market Value (US$ Bn), By Country/ Sub-region, 2019 & 2027

Figure 54:  Middle East & Africa Skin Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2019

Figure 55:  Global Skin Cancer Treatment Market Share (%), By Company, 2019

Table 1:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016–2027

Table 2:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016–2027

Table 3:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016–2027

Table 4:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016–2027

Table 5:  Global Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Region, 2016-2027

Table 6:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 7:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 8:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 9:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 10:  North America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country, 2016-2027

Table 11:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 12:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 13:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 14:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 15:  Europe Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 17:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 18:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 19:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 20:  Asia Pacific Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 22:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 23:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 24:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 25:  Latin America Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Table 26:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Disease Indication, 2016-2027

Table 27:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Therapy, 2016-2027

Table 28:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Modality, 2016-2027

Table 29:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2016-2027

Table 30:  Middle East & Africa Skin Cancer Treatment Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2016-2027

Booklet
  • May, 2020
  • 2019
  • 2016-2018
  • 140

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X